4//SEC Filing
Bodick Neil 4
Accession 0001209191-19-052748
CIK 0001419600other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:19 PM ET
Size
11.0 KB
Accession
0001209191-19-052748
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-10-07$13.98/sh−1,346$18,817→ 104,004 total - Exercise/Conversion
Restricted Stock Unit Award
2019-10-06−4,568→ 0 totalExp: 2019-10-06→ Common Stock (4,568 underlying) - Exercise/Conversion
Common Stock
2019-10-06+4,568→ 105,350 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F3]On January 4, 2016, the reporting person was granted up to 20,550 restricted stock units. The amount and vesting of the shares under the restricted stock unit award was based on the achievement of certain milestones that were established at the time of the Compensation Committee's approval of the restricted stock unit award on December 17, 2015. On October 6, 2017, the Compensation Committee certified the achievement of a milestone under the restricted stock unit award resulting in the commencement of vesting of 13,700 shares as follows: 4,566 shares vested as of October 6, 2017, 4,566 shares vested as of October 6, 2018 and 4,568 shares vested as of October 6, 2019.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001598099
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:19 PM ET
- Size
- 11.0 KB